Financial News
Latest News about pharmaceuticals
Recent news which mentions pharmaceuticals
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
January 26, 2024
From CNBC.com News
Humana stock plunges on dismal 2024 forecast, as insurers face soaring medical costs
January 25, 2024
From CNBC.com News
Johnson & Johnson to settle talc baby powder investigation, will reportedly pay $700 million
January 23, 2024
From CNBC.com News
Johnson & Johnson narrowly tops quarterly estimates as pharmaceutical, medtech sales jump
January 23, 2024
From CNBC.com News
Gilead stock falls after disappointing lung cancer study results
January 22, 2024
From CNBC.com News
Inflation-Busting Price Hikes For Ozempic, Mounjaro And Others: Are Drugmakers Profiteering?
January 18, 2024
From Benzinga
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
January 17, 2024
From CNBC.com News
Top pharma CEO says preparedness for a new pandemic has not improved
January 16, 2024
From CNBC.com News
Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
January 14, 2024
From CNBC.com News
From CNBC.com News
From Business Journals
Atea Pharmaceuticals' Hepatitis C Virus Candidate Shows Efficacy
January 09, 2024
From Benzinga
Short Seller's Bombshell Report Rattles Grifols: Stock Chart Points To Potential Further Decline
January 09, 2024
From Benzinga
Bristol-Myers CEO talks new acquisitions: 'We are writing the next chapter of this company'
January 08, 2024
From CNBC.com News
Walgreens CEO says company is using its stores and brand to boost health-care business
January 08, 2024
Tickers
CEO
From CNBC.com News
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
January 08, 2024
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
